Grifols SA (GRFS) ADR each Representing 1 Non Voting B Share

Sell:$6.93Buy:$6.94$0.07 (0.93%)

NASDAQ:0.27%
Prices delayed by at least 15 minutes
Sell:$6.93
Buy:$6.94
Change:$0.07 (0.93%)
Prices delayed by at least 15 minutes
Sell:$6.93
Buy:$6.94
Change:$0.07 (0.93%)
Prices delayed by at least 15 minutes

Company Information

About this company

Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. The Company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.

Key people

Jose Ignacio Abia
Chief Executive Officer, Executive Director
Alfredo Arroyo Guerra
Chief Financial Officer
Jordi Balsells Valls
President - Plasma Procurement
Alberto Grifols Roura
President - Bio Supplies
Antonio Martinez Martinez
President - Diagnostic
Montserrat Gaja Llamas
Chief Human Resource Officer
Lluis Pons Gomez
Senior Vice President - Strategy & COO Office
Miguel Angel Louzan Garcia
Chief Digital Information Officer
Joerg Schuettrumpf
Chief Scientific Innovation Officer
Francisco Javier Guix Huguet
Vice President - Healthcare Solutions
Thomas H. Glanzmann
Non-Executive Chairman of the Board, Other External Director
Montserrat Munoz Abellana
Lead Independent Director
Albert Grifols Coma-Cros
Proprietary Director
Victor Grifols Deu
Proprietary Director
Raimon Grifols Roura
Proprietary Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    Spain
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US3984384087
  • Market cap
    $5.67bn
  • Employees
    23,744
  • Shares in issue
    426.13m
  • Exchange
    Mercado Continuo Espana
  • Index
    IBEX 35 Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.